p21-activated kinase 2 (Pak2), a serine/threonine kinase, has been previously shown to be essential for hematopoietic stem cell (HSC) engraftment. However, Pak2 modulation of long-term hematopoiesis and lineage commitment remain unreported. Utilizing a conditional Pak2 knock out (KO) mouse model, we found that disruption of Pak2 in HSCs induced profound leukopenia and a mild macrocytic anemia. Although loss of Pak2 in HSCs leads to less efficient short-and longterm competitive hematopoiesis than wild type (WT) cells, it does not affect HSC self-renewal per se. Pak2 disruption decreased the survival and proliferation of multi-cytokine stimulated immature progenitors. Loss of Pak2 skewed lineage differentiation toward granulocytopoiesis and monocytopoiesis in mice as evidenced by 1) a three to six-fold increase in the percentage of 
Introduction
p21-activated kinases (Paks) are serine/threonine kinases that regulate diverse cellular activities including cytoskeletal remodeling, cell motility, cell proliferation, apoptosis and mitosis. [1] [2] [3] Based on structural and functional similarities, Paks are divided into two groups. Group I consists of Pak1, Pak2, and Pak3 and group II consists of Pak4, Pak5, and Pak6. 2 Among the six members of the Paks, Pak1, the most characterized isoform, is expressed in muscle, spleen, and brain. 4 Pak2 is expressed ubiquitously while Pak3 is expressed principally in brain. 5 Upregulation of Pak1 has been identified in a variety of human cancers, particularly hormone-dependent solid tumors, and is linked to tumor progression and poor survival in patients. 5 Although structurally highly homologous to Pak1, 6 recent studies suggest that Pak2 has shared and distinct functions in regulating cellular functions in different cell types. [7] [8] [9] [10] Few studies have examined the role of Paks in modulation of normal hematopoietic cell function and the pathogenesis of hematological malignancies. 2, 3, [11] [12] [13] Previous work in our laboratory demonstrated that Pak1 knockout (Pak1-KO) mice have normal BM cellularity and complete blood count (CBC) profiles, 14 and our unpublished data demonstrate that Pak1-KO hematopoietic stem cells (HSCs) reconstitute lethally irradiated mice as efficiently as wild type (WT) HSCs (D.W.C., unpublished). Thus, while Pak1 appears dispensable for steady-state hematopoiesis, a recent report demonstrated that Pak2 regulates HSC migration and engraftment. 15 However, Pak2's regulation of long-term hematopoiesis and lineage commitment remains unreported.
In this study, utilizing novel lentiviral vectors and a conditional Pak2-KO murine model, we show that Pak2 disruption reduces proliferation and survival of hematopoietic progenitor cells (HPCs) in vitro, and in vivo leads to profound peripheral blood leukopenia while contributing to granulocyte/monocyte skewing and T and B cell differentiation/maturation defects. Pak2 disruption does not compromise HSC self-renewal per se. Bone marrow (BM) analyses revealed normal phenotypic HSC (defined as Lin − Sca1 + c-Kit + CD150 + CD48/41 − ) numbers, reduced Lin − Sca1 + c-Kit + cell (enriched for HPC) numbers, and an increased frequency of granulocyte-monocyte progenitors (GMPs), suggesting that a proliferation deficiency and myeloid lineage bias occurs at the progenitor cell level.
Materials And Methods

Mice and genotyping
To generate the conditional Pak2-KO mice, Pak2 flox/flox mice (construction to be described elsewhere) were bred to Mx1Cre transgenic mice. Pak2 flox/flox Mx1Cre + and Pak2 flox/flox Mx1Cre − mice were treated with 20mg/g body weight of polyIC every other day for total of three doses. Within 24 hours following final dose, BM cells were collected and Pak2 expression determined by Western blotting. Mice were maintained at Indiana University School of Medicine. All studies were reviewed and approved by the Institutional Animal Care and Use Committee and the Institutional Review Board.
Isolation of BM cells and c-kit positive cells
Low density mononuclear cells (LDMNCs) were isolated by density gradient centrifugation as described. 16 LDMNCs were pooled from two femurs per mouse and enumerated using a hemocytometer. The absolute numbers of LDMNCs per femur were reported. C-kit + cells were isolated by magnetic cell sorting using a CD117 isolation kit (Miltenyi Biotec, Auburn, CA, USA), according to manufacturer's protocol, with >90% selection purity. Unless otherwise mentioned, cells were cultured in Iscove modified Dulbecco medium (IMDM, from Lift Technologies, USA) with 10% fetal bovine serum (FBS), 1% penicillin/ streptomycin, and 1% L-glutamine (Lonza, Walkersville, MD).
Transduction of cells with Lentiviral vectors
Lentiviral vectors encoding either enhanced green fluorescent protein (LVeGFP) or Cre recombinase-eGFP fusion protein (LVCre-eGFP) were used. The lentiviral eGFP backbone, helper plasmid, envelope plasmid and packaging 293T cells were generously provided by Dr. Helmut Hanenberg (Indiana University, Indianapolis). Cre recombinase cDNA was cloned into lentiviral eGFP backbone and virus generated using 293T cells, as described 17 . C-kit + BM LDMNCs were transduced with lentivirus at a multiplicity of infection of 100:1 in the presence of murine interleukin-6 (mIL-6, 200 U/mL), Flt3 ligand (100 ng/mL), and murine stem cell factor (mSCF, 100 ng/mL)(all cytokines from Peprotech, Rocky Hill, NJ), as described, with minor modification. 17 Four days post-transduction, GFP + cells were sorted by FACS and used for in vitro assays. Experiments involving recombinant DNA were conducted following the National Institute of Health guidelines.
Colony assays
Methylcellulose-based colony assays were performed using LDMNCs, as described. 16, 18, 19 Briefly, 20,000 sorted CD45.2 + BM LDMNCs were cultured in methylcellulose (MethoCult™ H4100, Stemcell Technologies, Vancouver, Canada) containing FBS (30%), β-mercaptoethanol, glutamine (1%), mSCF (100 ng/mL), murine granulocyte-macrophage-and erythropoietin (4 units/ml) in 35mm Nunclon gridded dishes (Thermo Scientific). This assay measures multi-cytokine stimulated immature progenitors 20, 21 . All colonies including CFU-GM, CFU-GEMM and BFU-E in each dish were scored and the sum was shown in figures. Each condition was plated in triplicate or six repeats. Cell cultures were incubated in a 37°C humidified incubator with 5% CO 2 . In some experiments, individual colonies were collected and cytospin preparations of the progenies were subjected to Wright-Giemsa staining. For colony assays with mGM-CSF, mM-SCF, mG-CSF, mSCF or mIL-3 alone, 25,000 sorted CD45.2+ BM LDMNCs were plated in 0.3% agar culture medium containing 10% FBS and respective single cytokines 20 . The absolute number of colonies was adjusted to reflect that contained per femur.
For multi-cytokine stimulated immature progenitor cell survival assays, equal numbers (2000 cells/35 mm dish) of lentiviral vector transduced GFP + Pak2 flox/flox c-kit + BM LDMNCs were serum starved in IMDM+1% BSA+100ng/ml mSCF for 0, 24, 48 and 72 hours prior to being plated for colony assay with mGM-CSF, mSCF, mIL-3 and EPO added to the culture as described above. All colonies including CFU-GM, CFU-GEMM and BFU-E in each dish were scored and the sum was used to calculate the percentage of survival.
Cell cycle analysis of functional progenitor cells that form colonies in vitro
In vitro high specific activity tritiated 3 H thymidine suicide assays were performed as previously described. 22 Briefly, CD45.2 + BM LDMNCs were pulse-treated with control medium or with medium containing high specific activity 3 H thymidine (50 mCi/mL, specific activity = 20 Ci/mmol; New England Nuclear, Boston, MA) for 30 minutes at 37°C. Cells were then washed three times with control medium before plating in clonogenic assays with mGM-CSF, mSCF, mIL-3 and EPO added to the culture as described above. The percentage of colony forming progenitors in S phase was determined by the following formula: Control colonies minus 3 H thymidine colonies, divided by control colonies. All colonies including CFU-GM, CFU-GEMM and BFU-E in each dish were scored and the sum was used for the calculation.
Western blotting
Whole cell lysates were generated from equivalent number of cells and applied to Western blotting as described. 23 Primary antibody was rabbit anti-Pak2 polyclonal antibody (Cell signaling Technology, Danvers, MA). Equal protein loading was monitored by using β-actin as an internal control.
Proliferation assay
C-kit + BM cells were cultured in IMDM+10% FBS without cytokines overnight before plating into 96 well round bottom plates and adding mSCF (100 ng/mL, Peprotech, Rocky Hill, NJ) for 18 hours. 3 H thymidine (1 mCi/well) (Amersham, Les Ulis, France) was added, and measured 6 hours later.
Annexin V staining
C-kit + BM cells were cultured in IMDM+2% bovine serum albumin (BSA) and 100ng/ml mSCF overnight. Cells were then stained for 7-Amino-Actinomycin (7-AAD) and Annexin V-PE using PE Annexin V Apoptosis Detection kit, following manufacturer's instructions (BD Pharmingen).
Cell cycle analysis of lentiviral vector transduced c-kit + cells
Cell cycle status of test cells was determined using propidium iodide (PI) staining, as previously described. 24 Briefly, cells were washed with cold phosphate-buffered saline (PBS) twice then stained with equal volume of PBS containing 0.1mg/ml PI (Behring Diagnositics, La Jolla, CA), 0.6% Nonidet P-40 (NP-40), and PBS containing 2mg/ml RNAse (Sigma) for 30 minutes. Sample were analyzed on a FACScan (BDIS) and data analyzed using ModFit software (Verity Software House).
Flow cytometry
Peripheral white blood cells, BM LDMNCs, splenocytes or thymocytes were incubated with fluorochrome conjugated anti-mouse antibodies in ∼100 μL of PBS with 2% FBS at 4°C for 40 minutes, as previously described. 19 One μg antibody was used per one million cells for each antibody. All antibodies were from BD Biosciences, BioLegend or eBiosciences. For lineage analysis, the following antibody panel was used: anti-CD45.1-APC, anti-CD45.2-PerCP-Cy5.5, anti-CD3e-FITC, anti-B220-HorizonV500, anti-CD8-PacificBlue, anti-CD4-APC eFluor 780 (eBiosciences), anti-Ly6G-PE-Cy7, and anti-11b/Mac1-PE. For BM HSC and HPC analysis, the following panel was used: FITC-conjugated anti-lineage markers (CD3, CD4, CD8, B220, Mac-1, Ly6G, Ter119), anti-Sca1-APC-Cy7, anti-c-Kit-PE, anti-CD150-APC, anti-CD41-PE-Cy 7, anti-CD48-PE-Cy 7, anti-CD135 ( . Single color compensation controls were included in each experiment using polystyrene microbeads (BD Biosciences). Data analysis was performed using FlowJo 7.6.3 software (TreeStar, WA). Gates were determined using fluorescence minus-one controls. The absolute number of phenotypically defined CD45.2 + cell population in femur, spleen or thymus was obtained by multiplying the percentage of indicated cell population by absolute number of BM LDMNCs per femur, splenocytes or thymocytes respectively. In all experiments, each recipient mouse received 3×10 6 total LDMNCs in 200 μL PBS. Two months following transplantation, Cre expression was induced by intraperitoneal (i.p.) injections of poly I poly C (polyIC, Sigma) dissolved in sterile PBS. Each transplanted mouse received a total of 6 escalating doses of polyIC starting at 10 μg/g body weight and ending with 25 μg/g (cumulative dose = 100 μg/g body weight). Peripheral blood was drawn from tail vein using di-potassium EDTA (ethylenediaminetetraacetic acid) salt as an anticoagulant prior to first dose polyIC administration and at the indicated time points after transplantation. Peripheral white blood cells were isolated by incubating (15 minutes, 23 C) 30-50 μL of blood in RBC lysis buffer (Qiagen), followed by washing twice in PBS.
Transplantation, Mx1Cre induction, and blood isolation
For secondary transplantation, six months following polyIC administrations, 4×10 6 BM LDMNCs from primary recipients in the competitive transplantation experiments were injected into lethally irradiated CD45.1 + /CD45.2 + WT recipient mice. BM LDMNCs from each donor were injected into 3 or 4 secondary recipients.
Peripheral blood complete blood cell count
Peripheral blood was collected from mice in the non-competitive transplant cohort prior to and post polyIC injections. Complete blood cell count (CBC) was determined using Hemavet 950 machine (Drew Scientific) following manufacturer's instruction. The absolute number of CD45.2 + WBCs was generated by multiplying total WBC number with the percentage of CD45.2 + cells in the peripheral blood.
Histologic analysis
Eight months post polyIC administrations, tibiae from the non-competitively transplanted cohort were collected and fixed in 1% formaldehyde at room temperature for 6 hours and then embedded in paraffin. Hematoxylin-eosin (H&E) were performed using routine methods.
Quantitative Real-Time PCR
CD45.2 + Lin − kit + cells were sorted from LDMNCs from CD45.1 + BoyJ mice that were transplanted with CD45.2 + Pak2 flox/flox Mx1Cre + or Pak2 flox/flox Mx1Cre − marrow by FACS. mRNA was isolated using Miltenyi μMACS mRNA isolation kit (Miltenyi) and then reverse transcribed to cDNA using iScript reverse transcription supermix kit (Bio-Rad, Hercules, CA). Quantitative Real-Time PCR (qRT-PCR) was performed using SsoAdvanced universal probes supermix (Bio-Rad) and TaqMan probes against murine JunB, c-Myc, PU.1 and GAPDH (Appplied Biosystems). qRT-PCR detection was done on a Bio-Rad CFX96 thermocycler (Bio-Rad). 2-ΔΔCT method was used to analyze the gene expression levels as previously described. 27 
Statistics
Statistical analyses were performed with GraphPad Prism 5.0 or Excel. Data were reported as mean ± SE and were analyzed using unpaired two-tailed student's t tests or ANOVA with appropriate post-hoc comparisons. Differences yielding p<0.05 were defined as statistically significant.
Results
Conditional disruption of Pak2 in hematopoietic cells
Pak2 nullizygous mice die before embryonic age 8. 
Pak2 regulates HPC proliferation, survival and apoptosis
Prior studies suggested group I Paks regulate G1 to S transition in certain cell lines 28 as well as proliferation and survival in HPCs. 15 To further study Pak2 in HPCs, we cultured LVCre-eGFP or LVeGFP transduced GFP + Pak2 flox/flox c-kit + cells (enrich for HPCs) with SCF overnight to allow the cells to recover from the stress associated with flow cytometric sorting before their use in functional assays. Although most active as a co-stimulating factor for HPC and HSC proliferation, SCF has modest stimulating activity by itself 29, 30 and was therefore used in cell cycle and proliferation assays. Pak2-disrupted cells showed an ∼15% increase in the frequency of cells in the G0/G1 phase, a corresponding 14% decrease in S phase ( Figure 1A) , and an approximately 30-50% decrease in SCF-induced proliferation in Pak2-disrupted HPCs ( Figure 1B) , consistent with impaired transition from G0/G1 to S phase. Despite the survival signal provided by SCF, serum starved Pak2-disrupted progenitors demonstrated substantial impairment in multi-cytokine stimulated colony formation as evidenced by the more significant decrease in the sum of CFU-GM, CFU-GEMM and BFU-E when compared to WT cells, indicating a survival disadvantage ( Figure  1C) . Following serum starvation, Pak2-disrupted c-kit + cells rapidly underwent apoptosis, as compared to WT ( Figure 1D ).
Loss of Pak2 in HSCs leads to less efficient short-and long-term competitive hematopoiesis than WT cells
We performed competitive repopulation assays by isolating CD45. Figure 3A ) and CD45.2 + peripheral blood white blood cell (WBC) count ( Figure 3B ) when compared to mice transplanted with WT HSCs starting at one month post Pak2 deletion. These mice also developed a very mild but statistically significant macrocytic anemia ( Figure 3C and 3D ).
Pak2 disruption diminishes phenotypic HPC but preserves phenotypic HSC population
Given the striking leukopenia in mice reconstituted with Pak2-KO BM cells in the competitive and non-competitive transplant cohorts, we assessed phenotypically-defined HSC and HPC frequency and numbers in the BM of these mice. Despite the significant difference in peripheral blood WBC counts, we found no difference in the number of BM LDMNCs per femur between mice transplanted with Pak2-KO and WT BM cells (Supplementary Figure S.2A) . Histological examination also revealed no gross difference in total cellularity (Supplementary Figure S.2B) . However, Pak2-KO BM showed a 50% diminution in the frequency and total number of Lin − Sca1 + c-Kit + cell population that is enriched for HPCs ( Figures 4A-B , representative flow gating shown in Supplementary  Figure S. 3). When compared to mice transplanted with WT cells, those transplanted with Pak2-KO BM cells had approximately 50% less multi-cytokine stimulated colonies (the sum of CFU-GM, CFU-GEMM and BFU-E) per femur as assessed by colony assays containing GM-CSF, SCF, IL-3 and EPO ( Figure 4C ).
We reasoned that the reduction in the phenotypic HPC population might be the result of decreased proliferation of Pak2 deficient progenitors. Using high specific activity tritiated thymidine killing assays with GM-CSF, SCF, IL-3 and EPO added in the culture, we revealed a near 35% decrease in the percentage of Pak2-disrupted multi-cytokine stimulated colonies in S phase ( Figure 4D ), consistent with decreased numbers of these colonies ( Figure 4C ). Figure 5D ) of PMNs than those transduced with LVeGFP. Cytospin preparations of the progenies from the multi-cytokine stimulated colony assays shown in Figure 4C were subjected to WrightGiemsa staining and morphological evaluation. We observed a significantly higher percentage of PMNs in the Pak2-KO progenies ( Figure 5E-i to iii) . In summary, we have provided several lines of evidence that Pak2 disruption in HSCs induces myeloid skewing, particularly increased granulocytopoiesis. Interestingly, higher frequency of neutrophil nuclear hypersegmentation (greater than 5 lobes) was observed in the peripheral blood from mice transplanted with Pak2-KO BM, suggesting granulocyte dysplasia ( Figure 5F -i to v).
We then examined SLAM-LSK cells (Lin
Altered myeloid transcription factor gene expression in Pak2-KO HSCs and HPCs
To begin to understand possible underlying mechanisms by which Pak2 regulates myeloid lineage differentiation, we examined gene expression levels of several transcription factors that are known to regulate myelopoiesis. Pak2 disruption led respectively to an approximately 3-fold decrease and 2-fold increase in JunB and Myc expression levels in Lin − kit + cells, a population of cells that are enriched for HSCs and HPCs ( Figure 6 ). There was no difference in PU.1 expression between the two groups.
Loss of Pak2 leads to deficient lymphopoiesis
One may argue that the observed myeloid skewing is simply due to more profound defect in lymphoipoiesis. We next evaluated the lymphoid lineages in the BM, thymus, spleen and blood from mice transplanted with Pak2-KO BM. We found no differences in the numbers of phenotypic common lymphoid progenitors (CLPs: 
Discussion
Here, utilizing a Pak2 flox/flox mouse model, we assessed the functional consequence of HSCautonomous Pak2 disruption in vivo. Transplanted Pak2-disrupted HSCs produced profound peripheral leukopenia, mild macrocytic anemia, myeloid skewing and T and B cell differentiation/maturation defects. Although loss of Pak2 in HSCs leads to less efficient short-and long-term competitive hematopoiesis than wild type (WT) cells, it does not affect HSC self-renewal per se. Pak2-disrupted BM maintains its cellularity and phenotypic HSCs. However, Pak2 disruption diminished numbers of phenotypically-defined HPCs ( Figure 4A -B) and multi-cytokine stimulated immature progenitors ( Figure 4C ) in BM. Our data suggest that Pak2 regulates HPC function. As Pak2 is a major downstream effector of the Rho GTPases Cdc42 and Rac, our finding agrees with the reports that Rac GTPases regulate HSC and HPC proliferation, survival, and apoptosis. [32] [33] [34] Our finding that Pak2 disruption leads to severe leukopenia in mice ( Figure 3A-B) is consistent with decreased numbers of HPCs ( Figure 4A-B) and multi-cytokine stimulated progenitors in Pak2-KO BM (Figure 4C ), which may be explained by impaired survival ( Figure 1A , S.6D) and proliferation of Pak2-KO HPCs ( Figure 4D ). When specific progenitors were examined, we found that Pak2 disruption selectively increases GM-CSF colony forming progenitors ( Figure 5C-D) while decreasing G-CSF, M-CSF and IL-3 stimulated progenitors in BM (Supplementary Figure S6) . This data clearly demonstrates Pak2's selective regulation of GM-CSF responding colony forming progenitors. Since Pak1, a structurally highly homologous isoform of Pak2, is known to regulate Ras signaling 35 , which mediates GM-CSF signaling transduction 36 , it is possible that Pak2 may modulate GM-CSF signaling. Work is ongoing to examine how loss of Pak2 alters GM-CSF signaling pathway in HPCs.
Pak2's apparent negative regulation of granulocyte and monocyte lineage commitment is intriguing. Myeloid differentiation requires coordination of multiple transcription factors exerting their functions at different levels of the HSC and HPC hierarchy. 37 JunB, a component of the Activator Protein-1 (AP-1) transcription factor, is a transcriptional regulator of myelopoiesis. 38, 39 Loss of JunB in myeloid lineage leads to increased numbers of granulocyte progenitors and ultimately myeloproliferative disease in mice. 38, 39 Our findings that Pak2 disruption in HSCs leads to increased percentages of phenotypically defined GMP ( Figure 5B ) and increased responsiveness to GM-CSF ( Figure 5C In addition to myeloid skewing, mice transplanted with Pak2-KO BM also develop hypersegmented neutrophils, sharing some of the phenotype found in mice with STAT3 deficient hematopoietic cells. 46 Given that STAT3 directly activates Rac1 47 A number of Pak inhibitors are under development as novel agents particularly in hormone dependent solid cancers. [48] [49] [50] However, few studies have addressed the implication of Paks regulation of normal and leukemic HPC functions. Our findings that Pak2 disruption in HSCs induces severe leukopenia, granulocyte-monocyte skewing and T and B cell differentiation/maturation defects may have potential implications in targeting Pak2 to treat both hematological and non-hematological malignancies. Furthermore, our observation indicates that the potential hematological side effects following Pak2 inhibition may warrant consideration. 
Conclusion
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Pak2 flox/flox c-kit + BM cells were untransduced or transduced with lentiviral vectors encoding either eGFP (LVeGFP) or Cre-eGFP (LVCre-eGFP). GFP + cells were sorted and used. (A) Cells were cultured in IMDM+10% FBS+100ng/ml of mSCF for 24 hours before cell cycle analysis. Panels (i) and (ii) demonstrate the pooled G0/G1 phase and S phase data from at least 3 mice, respectively. Student t test, p<0.05. (B) Cells were cultured overnight in IMDM+10% FBS without cytokines before being plated in IMDM+1%BSA and stimulated with 100ng/ml SCF for 18 hours. 3 H incorporation was measured. Hest, p<0.001. (C) Cells were serum starved in IMDM+1% BSA+100ng/ml mSCF for indicated time period prior to being plated for multi-cytokine stimulated colony assay with IL-3, SCF, GM-CSF and EPO added to the culture. All colonies including CFU-GM, CFU-GEMM and BFU-E in each dish were scored and the sum was used to calculate the percentage of survival. Y axis indicates colony formation as percentage of that at hour 0. 
